Dr Paul Turner is a Reader/Clinician Scientist and Honorary Consultant at Imperial, and Clinical Associate Professor at the University of Sydney, Australia. His research, funded by the Medical Research Council, European Commission and UK Food Standards Agency among others, focusses on the pathophysiology of severe allergic reactions to food. He is a member of the UK Food Standards Agency's Science Council, the United Nations Food & Agriculture Organization and World Health Organization Codex Expert Consultation on Risk Assessment of Food Allergens, and leads the EAACI Taskforce on Food Allergen Thresholds.
Paul trained in Paediatric Allergy and Immunology in Sydney (where he was mentored by Andrew Kemp and Dianne Campbell) and Great Ormond Street Hospital, London. He is a graduate of Oxford University and the University of London, and undertook a PhD investigating the immunopharmacology of allergic rhinitis under John Foreman (University College London) and Glenis Scadding (Royal National Throat Nose & Ear Hospital).
Paul leads the food allergy desensitisation programme at St Mary's Hospital, London; the team was awarded the Best UK Clinical Team by Allergy UK in 2018. Paul was the recipient of the 2020 PhARf Award, awarded by the European Academy of Allergy and Clinical Immunology (EAACI). He is a consultant to the UK Health Security Agency, and Chairperson of the World Allergy Organization (WAO) Anaphylaxis Committee. He co-leads the Anaphylaxis Working Group at the Resuscitation Council UK.
Paul is an active member and ex-chairperson of the BSACI Paediatric Allergy Group, where he has led the project to institute nationwide Allergy Action Plans for children with life-threatening allergies (see www.sparepensinschools.uk). He is also an advisor to Allergy UK, and the Anaphylaxis Campaign. He teaches on a number of University Courses including the MSc in Allergy at Imperial College, and is a renowned speaker at international meetings.
Turner P, 2022, Predicting probability of tolerating discrete amounts of peanut protein in allergic children using epitope-specific IgE antibody profiling, Allergy, ISSN:0105-4538
et al., 2022, Effect of priming interval on reactogenicity, peak immunological response, and waning after homologous and heterologous COVID-19 vaccine schedules: exploratory analyses of Com-COV, a randomised control trial, The Lancet Respiratory Medicine, ISSN:2213-2600
Shaker M, Turner PJ, Greenhawt M, 2022, Reply to "Food allergy: One more book rather than one less pen"., J Allergy Clin Immunol Pract, Vol:10, Pages:1670-1671
et al., 2022, “Too high, too low”: the complexities of using thresholds in isolation to inform precautionary allergen (“may contain”) labels, Allergy, Vol:77, ISSN:0105-4538, Pages:1661-1666
et al., 2022, British Society of Gastroenterology (BSG) and British Society of Paediatric Gastroenterology, Hepatology and Nutrition (BSPGHAN) joint consensus guidelines on the diagnosis and management of eosinophilic oesophagitis in children and adults, Gut, ISSN:0017-5749